X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4908) 4908
Book Review (1083) 1083
Publication (674) 674
Book Chapter (87) 87
Conference Proceeding (84) 84
Dissertation (34) 34
Book / eBook (9) 9
Government Document (7) 7
Web Resource (5) 5
Magazine Article (4) 4
Streaming Video (3) 3
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3648) 3648
humans (3283) 3283
animals (2527) 2527
cancer (1748) 1748
oncology (1733) 1733
mice (1713) 1713
cell line, tumor (1493) 1493
oncolytic virotherapy (1452) 1452
oncolytic virotherapy - methods (1323) 1323
medicine, research & experimental (1212) 1212
viruses (1036) 1036
oncolytic virus (1034) 1034
biotechnology & applied microbiology (1028) 1028
oncolytic viruses - genetics (1007) 1007
female (964) 964
health aspects (932) 932
genetics & heredity (906) 906
gene therapy (888) 888
neoplasms - therapy (879) 879
adenoviridae - genetics (831) 831
tumors (830) 830
immunotherapy (827) 827
virus replication (752) 752
therapy (751) 751
care and treatment (749) 749
apoptosis (748) 748
mice, nude (726) 726
xenograft model antitumor assays (712) 712
research (693) 693
oncolytic adenovirus (661) 661
oncolytic viruses (638) 638
adenovirus (612) 612
virotherapy (593) 593
oncolytic viruses - physiology (584) 584
male (579) 579
oncolysis (576) 576
in-vivo (539) 539
article (517) 517
adenoviruses (508) 508
genetic therapy - methods (501) 501
expression (490) 490
cells (468) 468
genetic aspects (468) 468
virology (467) 467
gene-therapy (461) 461
gene expression (451) 451
replication (451) 451
genetic vectors (446) 446
chemotherapy (420) 420
herpes-simplex-virus (412) 412
biochemistry & molecular biology (410) 410
mice, inbred balb c (394) 394
genetic vectors - genetics (376) 376
combined modality therapy (364) 364
cancer therapies (342) 342
melanoma (340) 340
proteins (334) 334
genetic therapy (332) 332
adenoviridae - physiology (326) 326
genetics (323) 323
cell biology (317) 317
molecular biology (307) 307
pharmacology (300) 300
infection (299) 299
analysis (297) 297
immunology (293) 293
phase-i trial (290) 290
clinical trials (285) 285
molecular medicine (285) 285
disease models, animal (282) 282
review (279) 279
vesicular stomatitis-virus (271) 271
drug discovery (262) 262
cell line (260) 260
neoplasms - genetics (260) 260
phase-i (255) 255
tumor-cells (255) 255
metastasis (252) 252
oncolytic viruses - immunology (251) 251
neoplasms - virology (248) 248
oncolytic (244) 244
usage (243) 243
original (240) 240
neoplasms - immunology (238) 238
treatment outcome (236) 236
virus (236) 236
vectors (233) 233
ovarian-cancer (231) 231
tumor cells, cultured (229) 229
pharmacology & pharmacy (224) 224
oncolytic viruses - metabolism (223) 223
mice, inbred c57bl (221) 221
cytotoxicity (220) 220
efficacy (219) 219
brain neoplasms - therapy (218) 218
biology (216) 216
neoplasms. tumors. oncology. including cancer and carcinogens (216) 216
physiological aspects (216) 216
vaccinia virus (216) 216
genetic engineering (214) 214
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4920) 4920
Japanese (36) 36
Chinese (35) 35
Russian (19) 19
German (15) 15
French (10) 10
Korean (7) 7
Spanish (6) 6
Polish (4) 4
Hungarian (3) 3
Croatian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2012, Methods in molecular biology, ISBN 9781617793394, Volume 797., x, 241
Book
Cancer Letters, ISSN 0304-3835, 2016, Volume 376, Issue 2, pp. 240 - 248
Highlights • Induction of Epstein–Barr virus lytic infection is a potential therapeutic strategy for treating EBV positive tumors. • Cordycepin can induce EBV... 
Hematology, Oncology and Palliative Medicine | EBV-associated tumors | Doxorubicin | Epstein–Barr virus | Cordycepin | Epstein-Barr virus | ACTIVATION | VIRAL LATENCY | BREAST-CANCER | B-CELLS | NASOPHARYNGEAL CARCINOMA | INDUCTION THERAPY | ONCOLOGY | THERAPEUTIC TARGET | GROWTH | GENE-EXPRESSION | EBV | Phosphorylation | Antibiotics, Antineoplastic - pharmacology | Humans | Herpesvirus 4, Human - drug effects | Stomach Neoplasms - metabolism | Oncolytic Viruses - pathogenicity | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | Transfection | RNA Interference | Time Factors | Protein Kinase C - metabolism | Herpesvirus 4, Human - pathogenicity | Oncolytic Viruses - drug effects | p38 Mitogen-Activated Protein Kinases - metabolism | Stomach Neoplasms - genetics | Stomach Neoplasms - virology | CCAAT-Enhancer-Binding Protein-beta - genetics | Stomach Neoplasms - therapy | Mice, SCID | CCAAT-Enhancer-Binding Protein-beta - metabolism | Oncolytic Virotherapy | Xenograft Model Antitumor Assays | Animals | Virus Activation - drug effects | Signal Transduction - drug effects | Tumor Burden - drug effects | Cell Line, Tumor | Deoxyadenosines - pharmacology | Doxorubicin - pharmacology | Anthracyclines | Drug therapy | Health aspects | Tumors | Chemotherapy | Microbiology | Lymphomas | Mitogens | Protein kinases | Cancer | Protein binding | Immunoglobulins | Genes | Viruses | Infections | Metastasis | Kinases | Proteins | Studies | Signal transduction | Chinese medicine | Cell cycle | Drug dosages | Apoptosis | Index Medicus
Journal Article
EMBO Molecular Medicine, ISSN 1757-4676, 05/2017, Volume 9, Issue 5, pp. 638 - 654
Bladder cancer has a recurrence rate of up to 80% and many patients require multiple treatments that often fail, eventually leading to disease progression. In... 
ribonucleotide reductase | vaccinia virus | bladder cancer | oncolytic virus | immunotherapy | THYMIDINE KINASE | MEDICINE, RESEARCH & EXPERIMENTAL | TUMOR-MODEL | BACILLUS-CALMETTE-GUERIN | DENDRITIC CELLS | CLINICAL-TRIAL | INTRAVESICAL THERAPY | PEXA-VEC JX-594 | POXVIRUS | GENE-THERAPY | CARCINOMA | Humans | Viral Proteins - immunology | Urinary Bladder - pathology | Ribonucleotide Reductases - immunology | Immunity | Vaccinia virus - genetics | Vaccinia virus - immunology | Gene Deletion | Urinary Bladder Neoplasms - pathology | Female | Tumor Cells, Cultured | Rats | Viral Proteins - genetics | Oncolytic Viruses - genetics | Urinary Bladder - immunology | Oncolytic Virotherapy | Animals | Virus Replication | Mice, Nude | Oncolytic Viruses - immunology | Urinary Bladder Neoplasms - therapy | Oncolytic Viruses - physiology | Urinary Bladder Neoplasms - immunology | Cell Line, Tumor | Mice, Inbred BALB C | Ribonucleotide Reductases - genetics | Vaccinia virus - physiology | Explants | Animal models | Toxicity | BCG | Cytotoxicity | Lymphocytes T | Regression analysis | Tumor cell lines | Cancer therapies | Bladder cancer | Ribonucleotide reductase | Clonal deletion | Urinary bladder | Rodents | Oncolysis | Reductase | Tumors | Cancer | Index Medicus | Urogenital System | s | Genetics, Gene Therapy & Genetic Disease
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 11/2006, Volume 98, Issue 21, pp. 1546 - 1557
Journal Article
Gene Therapy, ISSN 0969-7128, 03/2013, Volume 20, Issue 3, pp. 255 - 261
Oncolytic viruses can be neutralized in the bloodstream by antiviral antibodies whose titers increase progressively with each exposure, resulting in faster... 
MEDICINE, RESEARCH & EXPERIMENTAL | NEUTRALIZING ANTIBODIES | BIOCHEMISTRY & MOLECULAR BIOLOGY | vesicular stomatitis virus | INNATE | ADENOVIRUS | VIROTHERAPY | HERPES-SIMPLEX-VIRUS | CANCER-PATIENTS | REPLICATION | THERAPY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | cyclophosphamide | antibodies | oncolytic | measles virus | ANTITUMOR EFFICACY | MYELOMA | Measles - virology | Cyclophosphamide - administration & dosage | Immunity, Humoral - immunology | Humans | Measles - immunology | Dose-Response Relationship, Drug | Measles virus - genetics | Time Factors | Immunosuppressive Agents - pharmacology | Immunosuppressive Agents - administration & dosage | Vesicular stomatitis Indiana virus - physiology | Cricetinae | Vesicular stomatitis Indiana virus - genetics | Mice, Inbred C57BL | Mice, Transgenic | Oncolytic Viruses - genetics | Measles virus - immunology | Oncolytic Virotherapy - methods | Animals | Cyclophosphamide - pharmacology | Oncolytic Viruses - immunology | Oncolytic Viruses - physiology | Immunity, Humoral - drug effects | Antibodies, Viral - immunology | Mice | Measles virus - physiology | Vesicular stomatitis Indiana virus - immunology | Physiological aspects | Cyclophosphamide | Dosage and administration | Immune response | Health aspects | Measles virus | Prescription drugs | Viruses | Gene therapy | Cancer | Immune system | Index Medicus | Lymphocytes | Oncolysis | Immune response (humoral) | Antibody response
Journal Article
Journal Article
2014, ISBN 9781466589773, xv, 479 p., 16 unnumbered p.s of plates
"Cancer-causing viruses, also called oncoviruses, play a key role in the development of certain cancers. They contribute to genetic changes that disrupt the... 
pathogenicity | Oncogenic Viruses | virology | Viral carcinogenesis | Antiviral Agents | Virus inhibitors | therapeutic use | Neoplasms | Oncolytic Virotherapy
Book
Journal of Virology, ISSN 0022-538X, 04/2018, Volume 92, Issue 7, p. e01948-17
A parainfluenza virus 5 (PIV5) with mutations in the P/V gene (P/V-CPI-) is restricted for spread in normal cells but not in cancer cells in vitro and is... 
Oncolytic viruses | Parainfluenza virus | DNA damage | DISEASE VIRUS | OVARIAN-CANCER | PERSISTENT INFECTION | I INTERFERON | EXCISION-REPAIR | SIMIAN-VIRUS-5 P/V MUTANT | VIROLOGY | CISPLATIN | PARAMYXOVIRUS SIMIAN-VIRUS-5 | TUMOR-SUPPRESSOR | oncolytic viruses | parainfluenza virus | V-PROTEIN | Index Medicus
Journal Article
Journal of Virology, ISSN 0022-538X, 2017, Volume 91, Issue 6
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2013, Volume 110, Issue 18, pp. 7306 - 7311
Journal Article